Matches in SemOpenAlex for { <https://semopenalex.org/work/W1147359013> ?p ?o ?g. }
- W1147359013 abstract "OBJECTIVE: To assess effect of switching to rotigotine transdermal system on severity of restless legs syndrome (RLS) in patients who experienced augmentation with prior oral dopaminergics.BACKGROUND: Augmentation (worsening of RLS symptoms) can be a major complication of long-term dopaminergic therapy. Clinical studies indicated low augmentation rates with rotigotine (only long-acting dopaminergic approved for RLS). Transdermal delivery maintains stable plasma levels over 24h.DESIGN/METHODS: AURORA (NCT01386944) was a 13-month non-interventional study. Patients with moderate-to-severe RLS and augmentation with oral dopaminergics were switched to rotigotine (physician’s independent decision). Primary outcome: Clinical Global Impression severity score (CGI-1). Secondary: treatment regimen for switch. Other: RLS-6, International RLS Rating Scale (IRLS), Augmentation Severity Rating Scale (ASRS), adverse events (AEs). Study completers were assessed for effectiveness.RESULTS: 102 patients enrolled, 99 (mean age±SD:64.2±11.1 years; female:68) received rotigotine. 46 patients completed the study; 3 were excluded from effectiveness analyses due to concomitant Parkinson’s disease. Most common discontinuation reasons: AEs (26 [primarily application site reactions: ASR]), lack of efficacy (14); 8 patients lost to follow-up. Among 43 completers, prior dopaminergics were: benserazide/levodopa (19); pramipexole (19); ropinirole (7); carbidopa/levodopa (2); levodopa (1). Mean±SD baseline CGI-1 was 5.3±0.7; median change in CGI-1 was -2.0[-2.5,-1.5] (Hodges Lehman estimate [95[percnt]CI]). 16/43 patients were CGI-1 responders (蠅50[percnt] improvement). 5 patients switched to rotigotine after >1-day drug holiday, 23 switched overnight, 9 had overlapping switch, and 6 received ongoing oral dopaminergics with rotigotine on Day 28. RLS-6 decreased with rotigotine. Mean±SD change in IRLS:-12.7±7.5. At final visit, patients had median ASRS=0 (i.e. no worsening/occurrence of augmentation); mean±SD:1.2±2.7. AEs: ASR (33), nausea (13), fatigue (9), depression (7), headache (6).CONCLUSIONS: Switching to 24h therapy with rotigotine (continuous dopaminergic stimulation) was effective in improving RLS severity among severely affected patients who tolerated rotigotine and remained on therapy for 13 months.Study Supported by: UCB Pharma Disclosure: Dr. Trenkwalder has received personal compensation for activities with UCB Pharma, Mundipharma, GlaxoSmithKline, and Britannia Pharmaceuticals. Dr. Benes has received personal compensation for activities with UCB Pharma and Mundipharma as an advisory board member. Novartis, Biogen Idec, Bayer, Teva, Serono and Genzyme Dr. Lang has received personal compensation for activities with Novartis, Biogen Idec, Bayer Pharmaceuticals Corp., Teva Neuroscience, EDM Serono, and Genzyme. Dr. Kelling has received personal compensation for activities with UCB Pharma as an employee. Dr. Berkels has received personal compensation for activities with UCB Pharma as an employee. Dr. Schollmayer has received personal compensation for activities with UCB Pharma as an employee. Employee of UCB Pharma," @default.
- W1147359013 created "2016-06-24" @default.
- W1147359013 creator A5004507825 @default.
- W1147359013 creator A5012304326 @default.
- W1147359013 creator A5022630766 @default.
- W1147359013 creator A5046754422 @default.
- W1147359013 creator A5050112907 @default.
- W1147359013 creator A5076681561 @default.
- W1147359013 creator A5077348434 @default.
- W1147359013 creator A5083982206 @default.
- W1147359013 creator A5088552578 @default.
- W1147359013 date "2015-04-06" @default.
- W1147359013 modified "2023-10-17" @default.
- W1147359013 title "First 1-year Real-life Study to Assess Management of Augmentation of Restless Legs Syndrome by Switching to Rotigotine Transdermal System (P7.304)" @default.
- W1147359013 hasPublicationYear "2015" @default.
- W1147359013 type Work @default.
- W1147359013 sameAs 1147359013 @default.
- W1147359013 citedByCount "0" @default.
- W1147359013 crossrefType "journal-article" @default.
- W1147359013 hasAuthorship W1147359013A5004507825 @default.
- W1147359013 hasAuthorship W1147359013A5012304326 @default.
- W1147359013 hasAuthorship W1147359013A5022630766 @default.
- W1147359013 hasAuthorship W1147359013A5046754422 @default.
- W1147359013 hasAuthorship W1147359013A5050112907 @default.
- W1147359013 hasAuthorship W1147359013A5076681561 @default.
- W1147359013 hasAuthorship W1147359013A5077348434 @default.
- W1147359013 hasAuthorship W1147359013A5083982206 @default.
- W1147359013 hasAuthorship W1147359013A5088552578 @default.
- W1147359013 hasConcept C118552586 @default.
- W1147359013 hasConcept C126322002 @default.
- W1147359013 hasConcept C138496976 @default.
- W1147359013 hasConcept C142724271 @default.
- W1147359013 hasConcept C15744967 @default.
- W1147359013 hasConcept C16568411 @default.
- W1147359013 hasConcept C197934379 @default.
- W1147359013 hasConcept C204787440 @default.
- W1147359013 hasConcept C205679159 @default.
- W1147359013 hasConcept C27081682 @default.
- W1147359013 hasConcept C2775842315 @default.
- W1147359013 hasConcept C2776000289 @default.
- W1147359013 hasConcept C2776750294 @default.
- W1147359013 hasConcept C2777453868 @default.
- W1147359013 hasConcept C2778715236 @default.
- W1147359013 hasConcept C2779134260 @default.
- W1147359013 hasConcept C2779424955 @default.
- W1147359013 hasConcept C2779734285 @default.
- W1147359013 hasConcept C2779989193 @default.
- W1147359013 hasConcept C2780304432 @default.
- W1147359013 hasConcept C42219234 @default.
- W1147359013 hasConcept C71924100 @default.
- W1147359013 hasConcept C83849319 @default.
- W1147359013 hasConcept C98274493 @default.
- W1147359013 hasConceptScore W1147359013C118552586 @default.
- W1147359013 hasConceptScore W1147359013C126322002 @default.
- W1147359013 hasConceptScore W1147359013C138496976 @default.
- W1147359013 hasConceptScore W1147359013C142724271 @default.
- W1147359013 hasConceptScore W1147359013C15744967 @default.
- W1147359013 hasConceptScore W1147359013C16568411 @default.
- W1147359013 hasConceptScore W1147359013C197934379 @default.
- W1147359013 hasConceptScore W1147359013C204787440 @default.
- W1147359013 hasConceptScore W1147359013C205679159 @default.
- W1147359013 hasConceptScore W1147359013C27081682 @default.
- W1147359013 hasConceptScore W1147359013C2775842315 @default.
- W1147359013 hasConceptScore W1147359013C2776000289 @default.
- W1147359013 hasConceptScore W1147359013C2776750294 @default.
- W1147359013 hasConceptScore W1147359013C2777453868 @default.
- W1147359013 hasConceptScore W1147359013C2778715236 @default.
- W1147359013 hasConceptScore W1147359013C2779134260 @default.
- W1147359013 hasConceptScore W1147359013C2779424955 @default.
- W1147359013 hasConceptScore W1147359013C2779734285 @default.
- W1147359013 hasConceptScore W1147359013C2779989193 @default.
- W1147359013 hasConceptScore W1147359013C2780304432 @default.
- W1147359013 hasConceptScore W1147359013C42219234 @default.
- W1147359013 hasConceptScore W1147359013C71924100 @default.
- W1147359013 hasConceptScore W1147359013C83849319 @default.
- W1147359013 hasConceptScore W1147359013C98274493 @default.
- W1147359013 hasLocation W11473590131 @default.
- W1147359013 hasOpenAccess W1147359013 @default.
- W1147359013 hasPrimaryLocation W11473590131 @default.
- W1147359013 hasRelatedWork W1206915386 @default.
- W1147359013 hasRelatedWork W1556432238 @default.
- W1147359013 hasRelatedWork W1563337686 @default.
- W1147359013 hasRelatedWork W1799485207 @default.
- W1147359013 hasRelatedWork W1997346120 @default.
- W1147359013 hasRelatedWork W2008052775 @default.
- W1147359013 hasRelatedWork W2036530028 @default.
- W1147359013 hasRelatedWork W2085156752 @default.
- W1147359013 hasRelatedWork W2089440371 @default.
- W1147359013 hasRelatedWork W2113326232 @default.
- W1147359013 hasRelatedWork W2120947429 @default.
- W1147359013 hasRelatedWork W2144366570 @default.
- W1147359013 hasRelatedWork W2180601340 @default.
- W1147359013 hasRelatedWork W2414506572 @default.
- W1147359013 hasRelatedWork W2473056721 @default.
- W1147359013 hasRelatedWork W2474667051 @default.
- W1147359013 hasRelatedWork W2810874204 @default.
- W1147359013 hasRelatedWork W3156271397 @default.
- W1147359013 hasRelatedWork W643028323 @default.
- W1147359013 hasRelatedWork W1889596662 @default.
- W1147359013 hasVolume "84" @default.